Marko Anderluh

Discovery of 4,5,6,7-Tetrahydrobenzo[1,2-<i>d</i>]thiazoles as Novel DNA Gyrase Inhibitors Targeting the ATP-Binding Site

Tihomir Tomašič, Sotirios Katsamakas, Žiga Hodnik et al. · Journal of Medicinal Chemistry · 2015 · 108 citations · Full text

Drug Target, Antibacterial Activity, Bacterial Dna Gyrase +16

TP53 exon-6 truncating mutations produce separation of function isoforms with pro-tumorigenic functions

Nitin H. Shirole, Debjani Pal, Edward R. Kastenhuber et al. · eLife · 2016 · 78 citations · Full text

5‐Benzylidenethiazolidin‐4‐ones as Multitarget Inhibitors of Bacterial Mur Ligases

Tihomir Tomašič, Nace Zidar, Andreja Kovač et al. · ChemMedChem · 2009 · 74 citations

Inhibitory Activity, Antimicrobial Drug Discovery, Antibiotics +14

Synthesis of Novel DC‐SIGN Ligands with an α‐Fucosylamide Anchor

Gabriele Timpano, Georges Tabarani, Marko Anderluh et al. · ChemBioChem · 2008 · 60 citations

Medicinal Chemistry, Natural Sciences, Coordination Complex +14

Toward a Novel Class of Antithrombotic Compounds with Dual Function. Discovery of 1,4-Benzoxazin-3(4<i>H</i>)-one Derivatives Possessing Thrombin Inhibitory and Fibrinogen Receptor Antagonistic Activities

Marko Anderluh, Janez Ilaš, Janez Mravljak et al. · Journal of Medicinal Chemistry · 2005 · 51 citations · Full text

Pharmacotherapy, Chemical Biology, Pharmaceutical Chemistry +24